• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1(GLP-1)可保护血管内皮细胞免受晚期糖基化终产物(AGEs)诱导的细胞凋亡。

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.

机构信息

Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

出版信息

Med Sci Monit. 2012 Jul;18(7):BR286-91. doi: 10.12659/msm.883207.

DOI:10.12659/msm.883207
PMID:22739729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560786/
Abstract

BACKGROUND

The peptide glucagon-like peptide-1 (GLP-1) is a hormone secreted by intestinal L cells in response to food intake. GLP-1 has been proposed as the basis of emerging therapy for patients with type 2 diabetes. However, the effects of GLP-1 on vascular injury in diabetes have not been identified. Advanced glycation end products (AGEs) induce endothelial cell apoptosis and have been implicated in the process of vascular complications from diabetes.

MATERIAL/METHODS: The aim of this work was to investigate whether and how GLP-1 protects endothelial cells from apoptosis induced by AGEs. Human umbilical vein endothelial cells (HUVECs) were treated with AGEs (200 µg/mL) for 48 h in the presence or absence of GLP-1. Cell morphology, viability, apoptosis, ratio of Bcl-2 protein to Bax protein, cytochrome c release, and activity of caspase-9 and -3 were determined.

RESULTS

Treatment of cells with AGEs led to cell morphology changes and decreased cell viability, resulting in apoptosis. GLP-1 alone increased cell viability in a concentration-dependent manner. GLP-1 partially inhibited AGEs-induced apoptosis in HUVECs. GLP-1 increased Bcl-2/Bax ratio, reduced cytochrome c levels in the cytoplasm, and reduced the activity of caspase-9 and -3 in AGEs-treated HUVECs.

CONCLUSIONS

AGEs induces apoptosis via the mitochondrion-cytochrome c-caspase protease pathway, and GLP-1 protects endothelial cells by interfering with this mechanism. GLP-1 may represent an anti-apoptotic agent in the treatment of vascular complications arising from diabetes.

摘要

背景

肽类激素胰高血糖素样肽-1(GLP-1)是一种在进食后由肠道 L 细胞分泌的激素。GLP-1 已被提议作为治疗 2 型糖尿病患者的新兴疗法的基础。然而,GLP-1 对糖尿病血管损伤的影响尚未确定。糖基化终产物(AGEs)诱导内皮细胞凋亡,并与糖尿病血管并发症的发生过程有关。

材料/方法:本研究旨在探讨 GLP-1 是否以及如何保护内皮细胞免受 AGEs 诱导的凋亡。将人脐静脉内皮细胞(HUVEC)用 AGEs(200μg/ml)处理 48 小时,同时存在或不存在 GLP-1。测定细胞形态、活力、凋亡、Bcl-2 蛋白与 Bax 蛋白的比值、细胞色素 c 释放和 caspase-9、caspase-3 的活性。

结果

用 AGEs 处理细胞导致细胞形态改变和细胞活力下降,从而导致细胞凋亡。GLP-1 以浓度依赖的方式单独增加细胞活力。GLP-1 部分抑制 HUVECs 中 AGEs 诱导的细胞凋亡。GLP-1 增加了 Bcl-2/Bax 比值,减少了细胞质中细胞色素 c 的水平,并降低了 AGEs 处理的 HUVECs 中 caspase-9 和 caspase-3 的活性。

结论

AGEs 通过线粒体-细胞色素 c-caspase 蛋白酶途径诱导细胞凋亡,GLP-1 通过干扰该机制来保护内皮细胞。GLP-1 可能是治疗糖尿病血管并发症的一种抗凋亡剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/49aafecb2155/medscimonit-18-7-BR286-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/f1bcbf711c48/medscimonit-18-7-BR286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/6bc0fb72b0c2/medscimonit-18-7-BR286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/335087961269/medscimonit-18-7-BR286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/49aafecb2155/medscimonit-18-7-BR286-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/f1bcbf711c48/medscimonit-18-7-BR286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/6bc0fb72b0c2/medscimonit-18-7-BR286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/335087961269/medscimonit-18-7-BR286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f35c/3560786/49aafecb2155/medscimonit-18-7-BR286-g004.jpg

相似文献

1
Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.胰高血糖素样肽-1(GLP-1)可保护血管内皮细胞免受晚期糖基化终产物(AGEs)诱导的细胞凋亡。
Med Sci Monit. 2012 Jul;18(7):BR286-91. doi: 10.12659/msm.883207.
2
Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.胰高血糖素样肽-1部分通过晚期糖基化终末产物受体途径减轻胰岛微血管内皮细胞中晚期氧化蛋白产物介导的损伤。
Int J Mol Med. 2016 Oct;38(4):1161-9. doi: 10.3892/ijmm.2016.2711. Epub 2016 Aug 19.
3
Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis.内源性晚期糖基化终产物受体保护血管内皮细胞免受 AGEs 诱导的细胞凋亡。
Biomed Res Int. 2018 Apr 10;2018:8216578. doi: 10.1155/2018/8216578. eCollection 2018.
4
[Role of p38MAPK/eNOS signaling pathway in the inhibition of AGEs-induced apoptosis of human umbilical vein endothelial cells by glucagon-like peptide-1].[38丝裂原活化蛋白激酶/内皮型一氧化氮合酶信号通路在胰高血糖素样肽-1抑制晚期糖基化终末产物诱导的人脐静脉内皮细胞凋亡中的作用]
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jan;36(1):116-9, 139.
5
Hepatocyte growth factor protects against apoptosis induced by advanced glycation end products in endothelial cells.肝细胞生长因子可保护内皮细胞免受晚期糖基化终产物诱导的细胞凋亡。
Chin Med Sci J. 2006 Mar;21(1):6-10.
6
[Effect of GLP-1 on high glucose-induced human umbilical vein endothelial cell apoptosis and mechanism].胰高血糖素样肽-1对高糖诱导的人脐静脉内皮细胞凋亡的影响及机制
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Oct;38(10):1029-34. doi: 10.3969/j.issn.1672-7347.2013.10.009.
7
[Involvement of p38 MAPK pathway in GLP-1-induced inhibition of apoptosis in human umbilical vein endothelial cells].p38丝裂原活化蛋白激酶信号通路参与胰高血糖素样肽-1诱导的人脐静脉内皮细胞凋亡抑制作用
Sheng Li Xue Bao. 2012 Aug 25;64(4):444-8.
8
Methylglyoxal-derived hemoglobin advanced glycation end products induce apoptosis and oxidative stress in human umbilical vein endothelial cells.甲基乙二醛衍生的血红蛋白晚期糖基化终产物诱导人脐静脉内皮细胞凋亡和氧化应激。
Int J Biol Macromol. 2021 Sep 30;187:409-421. doi: 10.1016/j.ijbiomac.2021.07.058. Epub 2021 Jul 13.
9
Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products.胰高血糖素样肽-1抑制晚期糖基化终末产物受体,以防止晚期氧化蛋白产物诱导的足细胞凋亡。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1413-1419. doi: 10.1016/j.bbrc.2016.12.050. Epub 2016 Dec 10.
10
Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice.远红外通过 PLZF 介导的自噬保护血管内皮细胞免受糖尿病小鼠中晚期糖基化终产物诱导的损伤。
Sci Rep. 2017 Jan 10;7:40442. doi: 10.1038/srep40442.

引用本文的文献

1
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress.糖尿病诱导的大血管和微血管并发症的病理生理机制:氧化应激的作用
Med Sci (Basel). 2025 Jul 2;13(3):87. doi: 10.3390/medsci13030087.
2
The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders.胰高血糖素样肽-1受体激动剂在神经认知障碍中的治疗作用及机制
Ther Adv Neurol Disord. 2025 Apr 17;18:17562864251332035. doi: 10.1177/17562864251332035. eCollection 2025.
3
Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action.

本文引用的文献

1
Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation.胰高血糖素样肽-1 通过上调血管内皮生长因子的生成来促进内皮祖细胞的增殖和分化。
Med Sci Monit. 2011 Feb;17(2):BR35-41. doi: 10.12659/msm.881383.
2
Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes.GLP-1 对 HL-1 心肌细胞的抗细胞凋亡作用。
Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1361-72. doi: 10.1152/ajpheart.00885.2010. Epub 2011 Jan 28.
3
Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
射血分数保留的不同类型心力衰竭病理生理学背景下的胰高血糖素样肽-1受体激动剂:潜在益处及作用机制
Card Fail Rev. 2024 Oct 16;10:e14. doi: 10.15420/cfr.2024.06. eCollection 2024.
4
Anti-atherosclerotic effect of incretin receptor agonists.肠促胰岛素受体激动剂的抗动脉粥样硬化作用。
Front Endocrinol (Lausanne). 2024 Oct 18;15:1463547. doi: 10.3389/fendo.2024.1463547. eCollection 2024.
5
Vitamin D3 mitigates myopathy and metabolic dysfunction in rats with metabolic syndrome: the potential role of dipeptidyl peptidase-4.维生素D3减轻代谢综合征大鼠的肌病和代谢功能障碍:二肽基肽酶-4的潜在作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3697-3715. doi: 10.1007/s00210-024-03439-3. Epub 2024 Oct 2.
6
Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes.晚期糖基化终末产物:糖尿病心血管并发症的关键介质和治疗靶点。
World J Diabetes. 2023 Aug 15;14(8):1146-1162. doi: 10.4239/wjd.v14.i8.1146.
7
EVOO's Effects on Incretin Production: Is There a Rationale for a Combination in T2DM Therapy?特级初榨橄榄油对肠降血糖素分泌的影响:在 T2DM 治疗中联合应用是否合理?
Int J Mol Sci. 2022 Sep 4;23(17):10120. doi: 10.3390/ijms231710120.
8
GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?GLP-1 激动剂治疗肥胖和预防心血管疾病:我们目前取得了哪些进展?
Curr Atheroscler Rep. 2022 Nov;24(11):867-884. doi: 10.1007/s11883-022-01062-2. Epub 2022 Aug 31.
9
Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway.利拉鲁肽通过 mTOR 信号通路改善血管内皮功能。
J Diabetes Res. 2021 Aug 16;2021:2936667. doi: 10.1155/2021/2936667. eCollection 2021.
10
Medical and Surgical Obesity Treatments and Atherosclerosis: Mechanisms beyond Typical Risk Factors.医学与外科肥胖治疗与动脉粥样硬化:典型风险因素之外的机制。
Curr Atheroscler Rep. 2021 Aug 5;23(10):60. doi: 10.1007/s11883-021-00961-0.
吡哆醇可改善体外糖基化终产物诱导的血小板一氧化氮合酶功能障碍。
Int J Vitam Nutr Res. 2010 Jun;80(3):168-77. doi: 10.1024/0300-9831/a000019.
4
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.糖基化终产物(AGEs)及其受体(RAGE)在糖尿病血管损伤中的作用。
Exp Gerontol. 2011 Apr;46(4):217-24. doi: 10.1016/j.exger.2010.11.007. Epub 2010 Nov 25.
5
Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15.胰高血糖素样肽-1 可拮抗晚期糖基化终产物对胰岛 β 细胞系 HIT-T15 的有害作用。
Biochem Biophys Res Commun. 2010 Jul 30;398(3):462-6. doi: 10.1016/j.bbrc.2010.06.100. Epub 2010 Jun 30.
6
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.Exendin-4 通过 eNOS、PKA 和 PI3K/Akt 依赖途径刺激人冠状动脉内皮细胞的增殖,并且需要 GLP-1 受体。
Mol Cell Endocrinol. 2010 Aug 30;325(1-2):26-35. doi: 10.1016/j.mce.2010.04.022. Epub 2010 May 7.
7
Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.胰高血糖素样肽 1 通过激活蛋白激酶 A 预防活性氧诱导的内皮细胞衰老。
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1407-14. doi: 10.1161/ATVBAHA.110.206425. Epub 2010 May 6.
8
Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.胰高血糖素样肽-1在血管内皮功能障碍中的作用。
Indian J Exp Biol. 2010 Jan;48(1):61-9.
9
Trends in advanced glycation end products research in diabetes mellitus and its complications.糖尿病及其并发症中晚期糖基化终产物研究的进展。
Mol Cell Biochem. 2010 Aug;341(1-2):33-41. doi: 10.1007/s11010-010-0434-5. Epub 2010 Mar 23.
10
Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.Exendin-4 通过肿瘤坏死因子-α(TNF-α)抑制 c-Jun N 末端蛋白激酶的激活,并抑制 TNF-α诱导的胰岛素分泌细胞凋亡。
Endocrinology. 2010 May;151(5):2019-29. doi: 10.1210/en.2009-1166. Epub 2010 Mar 10.